Amgen (AMGN)

Market Cap

$237.48B

Current · Retrieved: · USD

AMGN logo

AMGN Market Cap

Current$237.48B
AMGN Market Cap ($185.84M → $237.48B · CAGR +17.9%)
High-resolution chart · PNG

AMGN market cap history

Daily history. Dates identify market observations.

Amgen Market Cap — Daily history
DateMarket Cap
176,667,724,960
177,759,801,600
175,451,302,960
177,949,022,800
177,624,643,600
177,311,077,040
173,780,750,080
175,916,246,480
174,478,165,360
174,867,420,400
173,002,240,000
174,348,413,680
175,537,804,080
168,947,500,000
177,840,896,400
175,824,339,040
180,565,681,680
181,398,254,960
179,743,921,040
180,181,832,960
179,765,546,320
181,030,625,200
180,733,277,600
181,441,505,520
180,160,207,680
181,636,133,040
179,105,975,280
178,932,973,040
181,473,943,440
180,106,144,480
178,489,654,800
178,857,284,560
175,754,056,880
173,905,095,440
170,791,055,120
168,385,242,720
168,071,676,160
167,260,728,160
168,012,206,640
168,141,958,320
168,920,468,400
169,590,852,080
169,120,502,240
172,629,203,920
172,002,070,800
166,601,157,120
167,536,450,480
165,427,985,680
163,962,872,960
161,443,527,840
161,378,652,000
162,773,482,560
162,568,042,400
164,741,383,040
164,903,572,640
165,265,796,080
166,179,464,160
166,174,057,840
166,201,089,440
165,352,297,200
162,730,232,000
160,227,105,840
162,292,320,080
165,346,890,880
165,703,708,000
167,276,947,120
170,217,985,200
170,050,389,280
168,931,281,040
170,147,703,040
172,483,233,280
168,358,211,120
166,757,940,400
167,677,014,800
169,142,127,520
166,141,619,920
162,351,789,600
161,908,471,360
168,293,335,280
150,506,542,480
149,955,097,840
148,100,730,080
149,419,872,160
145,959,827,360
145,635,448,160
147,597,942,320
147,884,477,280
147,003,247,120
145,392,163,760
142,051,058,000
142,764,692,240
143,613,484,480
143,543,202,320
144,500,120,960
145,970,640,000
144,051,396,400
146,165,267,520
145,538,134,400
145,943,608,400
144,938,032,880
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.